Volume 11, Number 11—November 2005
Research
Neutralizing Antibody Response and SARS Severity
Table 6
Factor | Early seroresponders† |
OR | p value‡ | |
---|---|---|---|---|
Yes, n (%) | No, n (%) | |||
Died | ||||
Yes | 29.6 (8) | 7.8 (10) | 4.97 | 0.004 |
No | 70.4 (19) | 92.2 (118) | 1.00 | |
Died within 2 wk | ||||
Yes | 75.0 (6) | 10.0 (1) | 0.013 | |
No | 25.0 (2) | 90.0 (9) | ||
Age (y) | ||||
>60 (n = 14) | 42.9 (6) | 57.1 (8) | 0.01 | |
<60 (n = 141) | 14.9 (21) | 85.1 (120) |
*SARS, severe acute respiratory syndrome; OR, odds ratio.
†Early seroresponders are SARS patients who were seropositive for SARS neutralizing antibody during the first 2 weeks of illness.
‡p value based on Fisher exact test.
Page created: February 17, 2012
Page updated: February 17, 2012
Page reviewed: February 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.